newsfilter
← Latest News
Business Wire·

Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of Eosinophilic Esophagitis (EoE)

– EoE affects approximately 135,000 in the US and an estimated 132,000 patients in the EU4 and United Kingdom – Currently no FDA approved therapies in the US for the treatment of EoE Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) today announced th